A practical guide to CCFS-2026 for foreign-owned Indian subsidiaries
A 90-day window letting foreign-owned Indian subsidiaries clear their ROC compliance backlog at roughly 10% of standard penalty fees, written for foreign GCs, CFOs, and directors who need to act before the 15 July 2026 close.
What Foreign Counsel Need to Know Before Advising Clients on India-Facing Arbitration
Recent Supreme Court decisions on Sections 34/37 review, arbitrability where consent is disputed, and enforcement of foreign awards under Section 48.
Recent Developments in Pharma & Life Sciences IP in India
Quarter 1 of 2026 saw major court and policy developments shaping pharma and life sciences IP in India. This March edition covers biosimilar injunction standards, post-expiry patent revocation, export-manufacturing risk, key pharma trademark disputes, and fresh CGPDTM/DPIIT updates—with practical takeaways for innovators, generics, and healthcare brands.
Digital Personal Data Protection Rules 2025: Privacy, Competition & Corporate Compliance
India’s Digital Personal Data Protection (DPDP) Rules, 2025 mark a clear shift towards enforceable privacy governance, with the Data Protection Board now operational. This edition explains what the framework means for foreign businesses handling personal data linked to individuals in India, where privacy risk starts to overlap with competition law, and how DPDP compares with the EU GDPR. You will also find a practical readiness checklist, key takeaways, and a phased compliance timeline running through May 2027. Read the full newsletter for the details.
Arbitration in India: Balancing Autonomy and Judicial Oversight
Four decisions. Clear signals. This January 2026 disputes newsletter highlights fresh arbitration and commercial dispute rulings and the takeaways businesses should act on.
5 IP Shifts Indian Brands Can’t Ignore
India’s IP landscape moved faster than many brand owners realise in late 2025. This edition of our IPR newsletter breaks down five key shifts – from India’s first smell mark and tougher protection for well-known trademarks, to rising AI deepfake/personality rights disputes, expanding copyright battles, and stricter scrutiny of patent procedure and Section 12A.
ROC enforcement trends and FEMA changes for Indian and foreign businesses
This newsletter highlights critical compliance areas and emerging trends that corporates should monitor closely for the ease of doing business in India.
Balancing Judicial Intervention and Arbitral Autonomy
Through four recent judgments, Indian courts have continued to refine the balance between judicial oversight and arbitral autonomy. The judiciary has reinforced fairness, confidentiality, and contractual sanctity while upholding party consent and arbitral independence. From anti-arbitration injunctions to the powers of arbitral tribunals, these rulings collectively strengthen the integrity of India’s arbitration framework and reaffirm the courts’ role as guardians of equity—not intruders in the arbitral process.
Key IP Developments in India – Trademarks, Patents & Pharma Cases
This issue reviews a series of landmark cases addressing trademark disputes, clarity in patent prosecution, and enforcement of biosimilar patents in tightly regulated sectors.
India Corporate Law Update: August 2025 Compliance & Governance Brief
Stay ahead with our August 2025 India Business Law update covering key MCA, SEBI, RBI & FEMA changes impacting compliance, governance, and FDI strategy.
